ClaimCow is a platform that helps users find class action settlements they may qualify for, file claims, and track potential settlement payouts.

How does ClaimCow help with class action settlements?

ClaimCow helps users identify possible settlement opportunities, check basic eligibility, submit claim information, and monitor claim progress through the platform.

Do I need to be part of a lawsuit to use ClaimCow?

Users do not usually need to start a lawsuit themselves. Class action settlements often allow eligible consumers to submit claims if they meet the settlement requirements.

How do I know if I qualify for a settlement?

Eligibility depends on the rules of each settlement. ClaimCow helps users review settlement opportunities and answer relevant questions to understand whether they may qualify.

Can ClaimCow track my submitted claims?

ClaimCow is designed to help users manage and track class action settlement claims so they can stay updated and avoid missing potential payouts.

Is ClaimCow a law firm?

ClaimCow is a settlement discovery and claim assistance platform. Users should review the website information carefully and seek independent legal advice if they need legal guidance.

Illinois jury awards additional $17M in baby formula lawsuits against Abbott

A Chicago jury has ordered Abbott Laboratories to pay an additional $17 million in punitive damages in a set of lawsuits involving its preterm infant formula, bringing the total verdict to $70 million in a closely watched case tied to allegations that the company failed to warn about serious health risks for premature babies.

The ruling stems from a trial involving four families who claimed their infants developed necrotizing enterocolitis (NEC), a severe intestinal disease that can be life-threatening, after being fed Abbott’s Similac Special Care formula in neonatal intensive care units. Jurors first awarded $53 million in compensatory damages after finding Abbott liable for negligence, defective product claims, and failure to warn.

A second phase of deliberations concluded the following day with the additional $17 million punitive award, which is intended to punish conduct the jury deemed reckless and deter similar behavior in the future. The plaintiffs argued that Abbott knew or should have known that cow’s milk-based formulas used in premature infants could increase NEC risk, yet did not adequately disclose those risks to hospitals, parents, or medical providers.

The four children involved survived but reportedly suffered lasting complications, and several required surgery shortly after birth. Abbott has denied the allegations and maintains that its products are safe and medically necessary in situations where breast milk is unavailable or insufficient. The company has said it intends to appeal, arguing that scientific evidence does not support claims that its formula causes NEC and that regulatory guidance supports its use in neonatal care settings.

Are you owed money from a class action settlement?

ClaimCow finds, files and tracks claims on your behalf — automatically.

Check My Eligibility

$64M+Recovered for users

50,000+Active claimants

Freeto find how much you're owed

The case is part of a much larger wave of litigation involving infant formula manufacturers. Hundreds of similar lawsuits have been filed against Abbott and other companies, including Mead Johnson, over claims related to NEC and preterm infant feeding products. Previous verdicts in related cases have varied widely, including both defense wins and multimillion-dollar awards that are currently under appeal, reflecting an ongoing legal and scientific dispute at the center of the litigation.

While the $70 million verdict marks another significant development in the series of trials, legal experts note that it does not resolve the broader litigation, which continues to move through state and federal courts across the United States.

New to Class Action Settlements? Check out our introductory guide to Class Actions!